Terrie Kellmeyer reports a stock award at AVXL
By AlphaYouPublished Form 4
Kellmeyer Terrie
Reporting filer
Terrie Kellmeyer reports a stock award, not an open-market purchase or sale, in Anavex Life Sciences Corp.. Form 4 filed Nov 7, 2026 lists 1 entry.
- Disclosed
- Nov 7, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Kellmeyer Terrie | 2026-11-03 | A | Grant or award | 200000 | 0 | 200,000 | 4 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Kellmeyer Terrie
- Date
- 2026-11-03
- Code
- A
- Action
- Grant or award
- Quantity
- 200000
- Price
- 0
- Following holdings
- 200,000
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 1.20
- transaction Date: 2026-11-03
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 200000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-02
- underlying Security Title: Common Stock
- underlying Security Shares: 200000
- shares Owned Following Transaction: 200000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Kellmeyer Terrie: President and CEO, Director.
- F1: The option was granted pursuant to the terms of the Reporting Person's employment agreement with the Issuer, dated May 4, 2026, and vests in three substantially equal annual installments beginning on May 4, 2027
Original sources
Prepared automatically from public filing data. Report a correction.